BRCA1 and breast carcinoma: For example, an investigation of germline variants in 5,391 Slavic patients with breast cancer found 17 breast cancer patients in which two pathogenic variants were detected; 4 (1.4%) of these women were found to be CHEK2 and BRCA1 double heterozygotes.